METASTATIC ALVEOLAR SOFT PART SARCOMA
Clinical trials for METASTATIC ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could less medicine be enough? study tests lower cancer drug doses
Disease control Recruiting nowThis study is testing a new approach to dosing a cancer immunotherapy drug called atezolizumab. Researchers want to see if they can use blood tests to personalize the timing and amount of the drug, aiming to use lower doses less often while still keeping it effective. The goal is…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for rare cancer: Two-Drug attack on tough sarcoma
Disease control Recruiting nowThis study is testing if a combination of two drugs, atezolizumab and selinexor, can shrink tumors in patients with advanced alveolar soft part sarcoma, a rare and difficult-to-treat cancer. The trial is for patients whose cancer has continued to grow despite prior immunotherapy.…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC